TA的评论：接着我上面的问题 我们需要选择的species is from different kinds of vaccines like inactivated vaccine, attenuated vaccine made from a specific strain, as well as subunit vaccine made from a protein comprised by the strain. 本案的中国审查员并不觉得有问题 但美国审查员认为只能选一个vaccines so if we want to keep both of inactivated vaccine, and attenuated vaccine, do we need to argue this in the response to the restriction requirement or we just pick one and file a divisional application for another one? and file it this time or wait until examination of the parent invention?
www.zhihuiya.com
中国药企眼中的专利价值
TA的评论：好像没有声音哎
研发-临床前研究专利申请策略
TA的评论：接着我上面的问题 我们需要选择的species is from different kinds of vaccines like inactivated vaccine, attenuated vaccine made from a specific strain, as well as subunit vaccine made from a protein comprised by the strain. 本案的中国审查员并不觉得有问题 但美国审查员认为只能选一个vaccines so if we want to keep both of inactivated vaccine, and attenuated vaccine, do we need to argue this in the response to the restriction requirement or we just pick one and file a divisional application for another one? and file it this time or wait until examination of the parent invention?
研发-临床前研究专利申请策略
TA的评论：老师您好 我想请问一下实务问题 目前我们收到了美国专利局的non-unity restriction notice 需要选择其中一个发明以及一个species 我想请问如果不太同意审查员的认定 需要在回复中提出比较好 还是提分案申请比较好？另外该申请为一个parent application的加快审查提出的申请，那么分案需要现在提出 还是在母案审查时提出也可以。